Michael Megaly to Risk Assessment
This is a "connection" page, showing publications Michael Megaly has written about Risk Assessment.
Connection Strength
1.220
-
Incidence and Long-Term Outcomes of Stroke in Patients Presenting With ST-Segment Elevation-Myocardial Infarction: Insights From the Midwest STEMI Consortium. J Am Heart Assoc. 2021 12 07; 10(23):e022489.
Score: 0.161
-
Outcomes with retrograde versus antegrade chronic total occlusion revascularization. Catheter Cardiovasc Interv. 2020 11; 96(5):1037-1043.
Score: 0.140
-
Outcomes With Deferred Versus Performed Revascularization of Coronary Lesions With Gray-Zone Fractional Flow Reserve Values. Circ Cardiovasc Interv. 2019 12; 12(12):e008315.
Score: 0.140
-
Radial Versus Femoral Access in Chronic Total Occlusion Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2019 06; 12(6):e007778.
Score: 0.136
-
Outcomes with cilostazol after endovascular therapy of peripheral artery disease. Vasc Med. 2019 08; 24(4):313-323.
Score: 0.135
-
Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients. Cardiovasc Revasc Med. 2020 01; 21(1):78-85.
Score: 0.133
-
Outcomes with drug-coated balloons in small-vessel coronary artery disease. Catheter Cardiovasc Interv. 2019 04 01; 93(5):E277-E286.
Score: 0.131
-
Clinical Characteristics and Outcomes?of?STEMI Patients With Cardiogenic Shock and Cardiac Arrest. JACC Cardiovasc Interv. 2020 05 25; 13(10):1211-1219.
Score: 0.036
-
Use of Radiation Protection Measures in Live Percutaneous Coronary Interventions Cases at Interventional Scientific Meetings. JACC Cardiovasc Interv. 2020 04 13; 13(7):905-906.
Score: 0.036
-
Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2020 11; 96(5):1029-1035.
Score: 0.035
-
Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute?Myocardial Infarction. JACC Cardiovasc Interv. 2019 09 23; 12(18):1825-1836.
Score: 0.035
-
Impact of diastolic dysfunction on long-term mortality and quality of life after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 04 01; 95(5):1034-1041.
Score: 0.034
-
Low-Risk Transcatheter Versus Surgical Aortic Valve Replacement - An Updated Meta-Analysis of Randomized Controlled Trials. Cardiovasc Revasc Med. 2020 04; 21(4):441-452.
Score: 0.034
-
In-hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians. Catheter Cardiovasc Interv. 2019 04 01; 93(5):989-995.
Score: 0.033